Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-033601
Filing Date
2020-12-11
Accepted
2020-12-11 18:05:36
Documents
2
Period of Report
2020-12-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7450
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3772
  Complete submission text file 0000899243-20-033601.txt   12897
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
Moran Kyle (Reporting) CIK: 0001657765 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 201384623